Loading...
NPI 1154574390 · Ogden, UT · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Brice Williams is a ophthalmology physician provider located in Ogden, Utah. This profile covers 25 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Brice Williams |
| Address | 4403 Harrison Blvd. |
| City | Ogden |
| State | UT |
| ZIP | 84403 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | October 31, 2008 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $738.3K |
| Medicaid | $24.4K |
Payer mix is heavily Medicare‑weighted: lifetime Medicare revenue is $738.3K compared with $24.4K in Medicaid, so the provider’s financial scale and clinical activity are overwhelmingly tied to Medicare patients rather than Medicaid. This makes Medicare trends and reimbursement policies materially more important to the practice’s revenue picture.
Medicare revenue is highly concentrated in intravitreal injection and office exam codes: the top 3 Medicare codes by revenue (J2777, J0178, 92014) account for 67.4% of total Medicare revenue. The largest single Medicare driver is J2777 (11.7K claims, $29 avg paid/claim, $339.3K revenue — 46.0% of Medicare revenue), followed by J0178 (132 claims, $691 avg paid/claim, $91.2K revenue — 12.4%) and 92014 (861 claims, $77 avg paid/claim, $66.3K revenue — 9.0%), indicating dependence on intravitreal drug administration plus comprehensive office visits.
Medicaid billing is almost entirely driven by comprehensive and new-patient exams: the top 3 Medicaid codes account for 97.1% of Medicaid revenue, with 92014 (254 claims, $49 avg paid/claim, $12.4K — 50.6%) and 92004 (100 claims, $100 avg paid/claim, $10K — 40.7%) making up the vast majority. This suggests the provider’s Medicaid activity is focused on routine diagnostic and exam services rather than high-cost retinal therapeutics.
Competitive standing varies by service line: 92014 on Medicare ranks #2251 of 35415 (94th percentile) and is described as notably above typical national volume, indicating the provider is a high-volume office evaluator relative to peers. By contrast, J2777 ranks #893 of 2039 (56th percentile) and is characterized as typical volume nationally, while J0178 ranks #2859 of 3204 (10th percentile), reflecting modest-to-low participation in aflibercept administration compared with national peers.
Diagnostic imaging and retina monitoring appear to be a meaningful part of the clinical mix: 92134 (OCT) shows 457 claims, $28 avg paid/claim, $12.8K revenue and ranks in the 86th percentile nationally, which aligns with the high injection volume and supports an active medical retina workflow for disease monitoring and treatment decisions. High percentile imaging coupled with injection codes is consistent with a retina-focused ambulatory practice model.
Surgical cataract work and related procedures are present but secondary to injections and office visits: for Medicare, 67028 (507 claims, $86 avg paid/claim, $43.6K — 5.9%) and 66984 (102 claims, $408 avg paid/claim, $41.6K — 5.6%) contribute noticeable but smaller shares of revenue. The mix suggests the practice performs cataract surgery and YAG/secondary-cataract procedures alongside a larger injection and medical retina service line rather than being primarily a high-volume surgical center.
Medicaid reimbursement patterns show low per-claim payments for some routine services and high concentration risk: 92015 has 715 claims at $2 avg paid/claim producing $1.4K (5.8% of Medicaid revenue), illustrating low-margin, high-count vision screening activity in the Medicaid panel. Overall, the Medicaid book is small ($24.4K total) and heavily concentrated in a few exam codes, making that payer line financially marginal and susceptible to changes in visit volume or reimbursement.
The provider has long tenure in the Medicare system—NPI enumerated 2008-10-31 (~18 years ago)—which supports a stable billing history and likely established referral relationships. That duration combined with the pattern of high-volume office visits and active injection/imaging services suggests an established ophthalmology practice with a stable Medicare patient base and consistent service mix.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
25 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 11,700 | $30 | $339.3K |
| J0178 | Injection, aflibercept, 1 mg | 130 | $690 | $91.2K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 860 | $80 | $66.3K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 510 | $90 | $43.6K |
| 66984 | The provider inserts an artificial lens after removing an extracapsular cataract by aspiration or use of ultrasonic waves. This procedure is done without the use of an endoscopic laser probe to… | 100 | $410 | $41.6K |
| 68761 | The provider places a plug to close off the lacrimal punctum and block excessive drainage of tears. He performs this procedure to treat dry eye syndrome. | 360 | $80 | $28.8K |
| 66821 | The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract. | 80 | $250 | $21K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 300 | $60 | $18.8K |
| 66982 | The provider inserts an intraocular lens prosthesis after extracapsular cataract extraction using complex techniques and devices. He may perform this by means of an iris expansion device, providing… | 30 | $550 | $17.1K |
| J9035 | Injection, bevacizumab, 10 mg | 250 | $50 | $13.3K |
Showing 1–10 of 25
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
25 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 34 | 40 | 620 | $690 | $683.2K |
| J2777 | 14 | 20 | 13,140 | $30 | $523.9K |
| 66984 | 67 | 150 | 90 | $520 | $80.3K |
| 67028 | 27 | 60 | 440 | $90 | $61.7K |
| 66982 | 26 | 50 | 30 | $620 | $22.2K |
| 15823 | 21 | 20 | 30 | $470 | $21.9K |
| J9035 | 4 | 10 | 110 | $50 | $17.5K |
| 92014 | 9 | 330 | 140 | $70 | $16.6K |
| 66821 | 23 | 100 | 40 | $230 | $13.1K |
| 68761 | 2 | 20 | 40 | $100 | $11K |
Showing 1–10 of 25
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 250 | $50 | $12.4K |
| 92004 | The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits. | 100 | $100 | $10K |
| 92015 | The provider determines the process of determining if a patient's vision is less than 20/20 and by what amount so that corrective lenses or contact lenses can be prescribed and produced. | 720 | $1 | $1.4K |
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 20 | $40 | $700 |
How this provider's Medicaid billing volume and revenue compare to other Utah providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Utah median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 92012 | For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any… | 24 | 30 | 60 | $100 | $65K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 50 | 160 | 120 | $100 | $55.5K |
| 92004 | The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits. | 73 | 140 | 100 | $90 | $42.5K |
| 92015 | The provider determines the process of determining if a patient's vision is less than 20/20 and by what amount so that corrective lenses or contact lenses can be prescribed and produced. | 54 | 210 | 170 | $1 | $2.7K |
Other providers in the same ZIP code as Brice Williams, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.